181 related articles for article (PubMed ID: 30640822)
1. Human Fibrinogen Concentrate and Fresh Frozen Plasma in the Management of Severe Acquired Hypofibrinogenemia in Children With Acute Lymphoblastic Leukemia: Results of a Retrospective Survey.
Giordano P; Grassi M; Saracco P; Luciani M; Colombini A; Testi AM; Micalizzi C; Petruzziello F; Putti MC; Casale F; Consarino C; Mura RM; Mastrodicasa E; Notarangelo LD; Onofrillo D; Pollio B; Rizzari C; Tafuri S; De Leonardis F; Corallo PC; Santoro N
J Pediatr Hematol Oncol; 2019 May; 41(4):275-279. PubMed ID: 30640822
[TBL] [Abstract][Full Text] [Related]
2. Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature.
Raikar SS; Felker J; Patel KN; Lew G; Sidonio RF
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e470-e472. PubMed ID: 29401102
[TBL] [Abstract][Full Text] [Related]
3. Profile of thrombin generation in children with acute lymphoblastic leukemia treated by Berlin-Frankfurt-Münster (BFM) protocols.
Lejhancova-Tousovska K; Zapletal O; Vytiskova S; Strbackova P; Sterba J
Blood Coagul Fibrinolysis; 2012 Mar; 23(2):144-54. PubMed ID: 22227959
[TBL] [Abstract][Full Text] [Related]
4. [Acquired hypofibrinogenemia in patients with leukemia during steroid therapy].
Ogasawara F; Ito T; Nakamura M; Saeki K; Taniguti A; Togitani K; Kojima K
Rinsho Ketsueki; 2021; 62(3):193-195. PubMed ID: 33828014
[TBL] [Abstract][Full Text] [Related]
5. Supplementation of fibrinogen concentrate in children with severe acquired hypofibrinogenaemia during chemotherapy for acute lymphoblastic leukaemia: our experience.
Giordano P; Luciani M; Grassi M; De Leonardis F; Coletti V; Santoro N
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s156-7. PubMed ID: 23522893
[No Abstract] [Full Text] [Related]
6. Role of cranial radiotherapy for childhood T-cell acute lymphoblastic leukemia with high WBC count and good response to prednisone. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster groups.
Conter V; Schrappe M; Aricó M; Reiter A; Rizzari C; Dördelmann M; Valsecchi MG; Zimmermann M; Ludwig WD; Basso G; Masera G; Riehm H
J Clin Oncol; 1997 Aug; 15(8):2786-91. PubMed ID: 9256120
[TBL] [Abstract][Full Text] [Related]
7. Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Sarris A; Cortes J; Kantarjian H; Pierce S; Smith T; Keating M; Koller C; Kornblau S; O'Brien S; Andreeff M
Leuk Lymphoma; 1996 Mar; 21(1-2):85-92. PubMed ID: 8907274
[TBL] [Abstract][Full Text] [Related]
8. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
[TBL] [Abstract][Full Text] [Related]
9. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
[TBL] [Abstract][Full Text] [Related]
10. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
11. Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.
Rizzari C; Valsecchi MG; Aricò M; Conter V; Testi A; Barisone E; Casale F; Lo Nigro L; Rondelli R; Basso G; Santoro N; Masera G;
J Clin Oncol; 2001 Mar; 19(5):1297-303. PubMed ID: 11230471
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiency.
Ross C; Rangarajan S; Karimi M; Toogeh G; Apte S; Lissitchkov T; Acharya S; Manco-Johnson MJ; Srivastava A; Brand B; Schwartz BA; Knaub S; Peyvandi F
J Thromb Haemost; 2018 Feb; 16(2):253-261. PubMed ID: 29220876
[TBL] [Abstract][Full Text] [Related]
13. Congenital Fibrinogen Deficiency in India and Role of Human Fibrinogen Concentrate.
John MJ; Byreddy P; Modak K; Makkar M
Acta Haematol; 2021; 144(6):595-602. PubMed ID: 34091452
[TBL] [Abstract][Full Text] [Related]
14. Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.
Vecchi V; Aricò M; Basso G; Ceci A; Madon E; Mandelli F; Masera G; Massimo L; Pession A; Zanesco L
Cancer; 1993 Oct; 72(8):2517-24. PubMed ID: 8402470
[TBL] [Abstract][Full Text] [Related]
15. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
16. Prospective, Randomized Study of Fibrinogen Concentrate Versus Cryoprecipitate for Correcting Hypofibrinogenemia in Cardiac Surgery Patients.
Ayaganov D; Kuanyshbek A; Vakhrushev I; Li T
J Cardiothorac Vasc Anesth; 2024 Jan; 38(1):80-85. PubMed ID: 38016817
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients.
Abrahamyan L; Tomlinson G; Callum J; Carcone S; Grewal D; Bartoszko J; Krahn M; Karkouti K
JAMA Surg; 2023 Mar; 158(3):245-253. PubMed ID: 36598773
[TBL] [Abstract][Full Text] [Related]
18. The impact of prophylactic fresh-frozen plasma and cryoprecipitate on the incidence of central nervous system thrombosis and hemorrhage in children with acute lymphoblastic leukemia receiving asparaginase.
Abbott LS; Deevska M; Fernandez CV; Dix D; Price VE; Wang H; Parker L; Yhap M; Fitzgerald C; Barnard DR; Berman JN
Blood; 2009 Dec; 114(25):5146-51. PubMed ID: 19822902
[TBL] [Abstract][Full Text] [Related]
19. Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
Paolucci G; Masera G; Vecchi V; Marsoni S; Pession A; Zurlo MG
Med Pediatr Oncol; 1989; 17(2):83-91. PubMed ID: 2704341
[TBL] [Abstract][Full Text] [Related]
20. Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS. Japan Association of Childhood Leukemia Study.
Hongo T; Okada S; Ohzeki T; Ohta H; Nishimura S; Hamamoto K; Yagi K; Misu H; Eguchi N; Suzuki N; Horibe K; Ueda K
Pediatr Int; 2002 Jun; 44(3):293-9. PubMed ID: 11982900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
